化疗对肝细胞癌的影响:一项回顾性研究
Masahide Isowa1, Reo Hamaguchi1, Ryoko Narui1
1Japanese Society on Inflammation and Metabolism in Cancer, Nakagyo-ku, Kyoto, Japan.
Frontiers in oncology
|June 14, 2023
概括
与标准治疗相结合的化疗法可能会改善肝细胞癌 (HCC) 患者的治疗结果. 保持尿液pH值为7.0或更高与HCC患者的整体存活时间显著延长有关.
科学领域:
- 在瘤学瘤学.
- 临床医学 临床医学
- 生物化学 生化学
背景情况:
- 尽管治疗方面取得了进展,肝细胞癌 (HCC) 的复发仍然是一个挑战.
- 目前的HCC疗法没有显著延长患者的存活时间.
- 目前正在探索化疗法作为一种补充治疗,以改善HCC患者的预后.
研究的目的:
- 评估用化疗法治疗的HCC患者的临床结果.
- 为了研究尿液pH和HCC患者接受化治疗的整体存活率之间的关联.
主要方法:
- 从2013年到2020年在卡拉苏马瓦达诊所接受治疗的HCC患者的回顾性分析.
- 从诊断和 alkalization 治疗开始的整体存活时间 (OS) 的比较.
- 评估平均尿液pH值作为瘤微环境pH值的替代品及其与OS的相关性.
主要成果:
- 总共分析了29名HCC患者 (23名男性,6名女性).
- 从 alkalization 疗法开始,与pH < 7.0 (15.4个月) 患者相比,平均尿液pH ≥ 7.0 (未达到) 的患者的中位寿命显著更长.
- 尿液pH值≥7.0与改善的生存结果有关.
结论:
- 化疗法,当与标准治疗相结合时,可能为HCC患者提供更好的结果.
- 在化疗法后尿液pH值升高 (≥7.0) 似乎是HCC的积极预后指标.
- 需要进一步的研究来证实化疗法在HCC治疗中的作用.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K


